Medorekkusu
4586.TTSE GROWTHPharmaceutical
Filed as Medrx Co.,Ltd. (2022-08–2026-08)
Financials · Consolidated
| Fiscal year ended | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|---|
| Revenue | ¥128m | ¥258m | ¥30m | ¥59m | ¥8m | ¥115m |
| Operating income | −¥942m | −¥793m | −¥934m | −¥1.1bn | −¥1.1bn | — |
| Ordinary income | −¥937m | −¥755m | −¥931m | −¥1.1bn | −¥1.1bn | −¥1.1bn |
| Net income (owners) | −¥937m | −¥807m | −¥933m | −¥1.1bn | −¥1.1bn | −¥1.1bn |
| Total assets | ¥2.2bn | ¥2.3bn | ¥2.1bn | ¥1.4bn | ¥2.1bn | ¥2.3bn |
| Net assets / equity | ¥2.0bn | ¥2.2bn | ¥1.9bn | ¥1.2bn | ¥2.0bn | ¥2.1bn |
| Operating cash flow | −¥888m | −¥803m | −¥914m | −¥1.1bn | −¥924m | −¥985m |
| EPS (basic) | ¥-17.44 | ¥-18.56 | ¥-26.82 | ¥-43.81 | ¥-49.62 | ¥-68.61 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 13
| Period | Form | Figures |
|---|---|---|
| 2026-01-01 → 2026-06-30 | Half-year | 67 figures · EDINET |
| 2025-01-01 → 2025-12-31 | Annual | 181 figures · EDINET |
| 2025-01-01 → 2025-06-30 | Half-year | 67 figures · EDINET |
| 2024-01-01 → 2024-12-31 | Annual | 181 figures · EDINET |
| 2024-01-01 → 2024-06-30 | Half-year | 67 figures · EDINET |
| 2024-01-01 → 2024-03-31 | Quarterly Q1 | 41 figures · EDINET |
| 2023-01-01 → 2023-12-31 | Annual | 181 figures · EDINET |
| 2023-01-01 → 2023-09-30 | Quarterly Q3 | 45 figures · EDINET |
| 2023-01-01 → 2023-06-30 | Quarterly Q2 | 69 figures · EDINET |
| 2023-01-01 → 2023-03-31 | Quarterly Q1 | 43 figures · EDINET |
| 2022-01-01 → 2022-12-31 | Annual | 181 figures · EDINET |
| 2022-01-01 → 2022-09-30 | Quarterly Q3 | 45 figures · EDINET |
| 2022-01-01 → 2022-06-30 | Quarterly Q2 | 69 figures · EDINET |
26 more reports are still being processed.